Industry

DUBLIN–(BUSINESS WIRE)–The “Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis” report has been added to ResearchAndMarkets.com’s offering. This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Consumer Healthcare Market: Analysis By Category, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026” report has been added to ResearchAndMarkets.com’s offering. Consumer healthcare items include those for wellbeing, oral health, nutrition, and skin health. Consumer healthcare products primarily consist of over-the-counter (OTC) pharmaceuticals, … [Read more…]

Stein will lead market expansion and health plan adoption of unified digital platform BURLINGTON, Mass.–(BUSINESS WIRE)–HealthEdge announced today that veteran Alan Stein has joined the company as Chief Commercial Officer, responsible for go-to-market strategy, customer growth, and adoption of the HealthEdge Digital Platform. Stein brings more than 25 years of experience in healthcare technology to … [Read more…]

TORONTO–(BUSINESS WIRE)–LifeWorks Inc. (the “Company” or “LifeWorks”) (TSX: LWRK) held its special meeting of shareholders virtually on Thursday, August 4, 2022, where shareholders voted overwhelmingly in favour of the special resolution approving the proposed plan of arrangement with TELUS Corporation, with 99.93 per cent voting FOR the resolution. The sole purpose of the special meeting … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Nebulizers Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global nebulizer devices market is expected to grow from $0.99 billion in 2021 to $1.08 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The market is expected to grow to $1.46 billion in 2026 at a … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Rituximab Biosimilars Global Market Report 2022: By Application, By Distribution, By Route” report has been added to ResearchAndMarkets.com’s offering. The global rituximab biosimilars market is expected to grow from $1.77 billion in 2021 to $2.05 billion in 2022 at a compound annual growth rate (CAGR) of 16.1%. The growth is mainly due to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Generic Drugs Market (2022-2027) by Category, Applications, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Generic Drugs Market is estimated to be USD 374.14 Bn in 2022 and is expected to reach USD 631.58 Bn by 2027, growing at … [Read more…]

Seamless integration of endoscopy during lumbar interbody fusion procedures ST. PAUL, Minn.–(BUSINESS WIRE)–#OptiLIFEndo—Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces another milestone today with the limited launch of OptiLIF® Endo. This innovative, ultra-MIS system requires only one tubular retractor to seamlessly integrate endoscopes and endoscopic equipment into lumbar interbody fusion procedures. The … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Immunotherapy Market (2022-2027) by Product, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Immunotherapy Market is estimated to be USD 69.6 Bn in 2022 and is expected to reach USD 90.53 Bn by 2027, growing … [Read more…]

NACgraft Aims to Improve Quality-of-Life for Breast Cancer Patients RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–BioAesthetics Corporation today announced an additional clinical study for the BioAesthetics® NACgraft™ Acellular Allograft that will investigate its performance in subpopulations of breast cancer survivors and other individuals needing nipple reconstruction. The previously announced study at Stanford Medicine focuses on female breast … [Read more…]